PBYI

Puma Biotech Wins Big on FDA Approval of Breast Cancer Treatment

 Shares of Puma Biotechnology, Inc. (NASDAQ: PBYI) touched a multiyear high Tuesday after the company reported a key approval by the U.S. Food and Drug Administration (FDA). Specifically, the agency ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Cameco, Carvana, Chipotle, Magellan Midstream, Netflix, Puma Bio, SeaWorld and More

Stocks were indicated marginally lower on Tuesday, but the major equity indexes remain just under all-time highs. The bull market may now be well over eight years old, but investors ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Boeing, Costco, Intel, KeyCorp, NVIDIA, PayPal, Snap and Many More

Stocks were looking for direction as the second week of July kicks off. Still, the bear market is over eight years old and the market indexes are very close to ...
Read Full Story »

7 ASCO Stocks Moving on Cancer Study News (Updated)

Note: Share prices have been updated. The Annual Meeting for the American Society of Clinical Oncology (ASCO) is currently underway in Chicago, and the health care sector is on ...
Read Full Story »
hammered

4 Companies That Destroyed Shareholders Last Week

Now that the U.S. presidential election is over and markets have recovered to their highs, there are still some stocks holding back the markets from breaking even higher. 24/7 Wall ...
Read Full Story »
hammered

4 Companies That Destroyed Shareholders Last Week

24/7 Wall Street has picked out a few companies posting some of the largest losses for the past week. Some companies are hitting lows and creating huge shareholder losses while ...
Read Full Story »
Female patient on gurney

Puma Biotech Gears Up for Secondary Offering

Puma Biotechnology, Inc. (NYSE: PBYI) recently filed with the U.S. Securities and Exchange Commission (SEC) for a secondary offering. No pricing details were announced, except that the offering would be ...
Read Full Story »
reprimand

SEC Issues Charges Over Biotech Insider Activity

The U.S. Securities and Exchange Commission (SEC) recently charged the former senior director of regulatory affairs for Puma Biotechnology Inc. (NYSE: PBYI) with insider trading ahead of the company’s news ...
Read Full Story »
graph

6 Biotech and Biohealth Analyst Picks for 50% to 150% Upside

The world of biotech and pharmaceuticals has entered into a strange period. The presidential elections have many companies under fire over price control or price gouging issues. And valuations previously ...
Read Full Story »
thumbs up and down

Could Puma Biotech Double After This FDA Approval?

Puma Biotechnology Inc. (NYSE: PBYI) posted strong gains over the course of this past week, which began with some positive news from the U.S. Food and Drug Administration (FDA) and ...
Read Full Story »
upside

Why Key Analyst Sees Puma Biotech Practically Doubling

Puma Biotechnology Inc. (NYSE: PBYI) has made solid gains over the course of this week, starting with some positive news from the U.S. Food and Drug Administration (FDA), but now ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Alibaba, Amazon, Bed Beth & Beyond, Puma Biotechnology, SeaWorld and More

Stocks were indicated higher on Thursday morning, following the prior day's news that the Federal Reserve was holding interest rates flat. Even considering recent market volatility, it is obvious that ...
Read Full Story »
FDA_logo

Puma Biotech Rises on Key FDA Approval

Shares of Puma Biotechnology Inc. (NYSE: PBYI) had a strong gain in Tuesday’s session following some positive news from the U.S. Food and Drug Administration (FDA). The regulatory body announced that ...
Read Full Story »
Female patient on gurney

Is This the Turning Point Puma Biotech Investors Have Waited For?

Puma Biotechnology Inc. (NYSE: PBYI) watched its shares make a handy gain on Friday morning after the firm released updated results from its late-stage breast cancer trial. Although 2016 has been ...
Read Full Story »
Doctor, Health (pulse) copy

Key Movers to Look for Ahead of ASCO

The American Society of Clinical Oncology (ASCO) is in the process of gearing up for its annual meeting. At this meeting, cancer drug developers will share the results from their ...
Read Full Story »